Jon E. Angell

Array ( [id] => 6095745 [patent_doc_number] => 20020052013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Tumour-specific P450 protein' [patent_app_type] => new [patent_app_number] => 09/874166 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6452 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052013.pdf [firstpage_image] =>[orig_patent_app_number] => 09874166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402736 [patent_doc_number] => 20100305186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHODS FOR MEDIATING GENE SUPPRESSION' [patent_app_type] => utility [patent_app_number] => 10/297167 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12925 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305186.pdf [firstpage_image] =>[orig_patent_app_number] => 10297167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921919 [patent_doc_number] => 20020115216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Composition for delivery of compounds to cells' [patent_app_type] => new [patent_app_number] => 09/861014 [patent_app_country] => US [patent_app_date] => 2001-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15718 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115216.pdf [firstpage_image] =>[orig_patent_app_number] => 09861014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340656 [patent_doc_number] => 20020034501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Methods and compositions for promoting angiogenesis using monocytes' [patent_app_type] => new [patent_app_number] => 09/860657 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3471 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034501.pdf [firstpage_image] =>[orig_patent_app_number] => 09860657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935953 [patent_doc_number] => 20020061525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Sequences of trail variants' [patent_app_type] => new [patent_app_number] => 09/855544 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14870 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061525.pdf [firstpage_image] =>[orig_patent_app_number] => 09855544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 511987 [patent_doc_number] => 07196242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Methods for identifying novel therapeutics and diagnostics in the p53 pathway' [patent_app_type] => utility [patent_app_number] => 09/860113 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 9062 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196242.pdf [firstpage_image] =>[orig_patent_app_number] => 09860113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1339476 [patent_doc_number] => 06593511 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Models of chronic and acute inflammatory diseases' [patent_app_type] => B1 [patent_app_number] => 09/852448 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10654 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593511.pdf [firstpage_image] =>[orig_patent_app_number] => 09852448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797497 [patent_doc_number] => 20030176371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Antisense modulation of interferon gamma receptor 2 expression' [patent_app_type] => new [patent_app_number] => 09/843377 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176371.pdf [firstpage_image] =>[orig_patent_app_number] => 09843377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779150 [patent_doc_number] => 20030050232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Novel human proteins, polynucleotides encoding them and methods of using the same' [patent_app_type] => new [patent_app_number] => 09/839446 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47151 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050232.pdf [firstpage_image] =>[orig_patent_app_number] => 09839446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814817 [patent_doc_number] => 20020039791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Methods and compositions for inhibiting thrombin generation at the surface of cells' [patent_app_type] => new [patent_app_number] => 09/834760 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18226 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039791.pdf [firstpage_image] =>[orig_patent_app_number] => 09834760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7062862 [patent_doc_number] => 20010042520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Method for producing model animals for itching induced by disruption of cutaneous barrier function' [patent_app_type] => new [patent_app_number] => 09/829905 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5722 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20010042520.pdf [firstpage_image] =>[orig_patent_app_number] => 09829905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032037 [patent_doc_number] => 20020018767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Anti-cancer cellular vaccine' [patent_app_type] => new [patent_app_number] => 09/828825 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9168 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018767.pdf [firstpage_image] =>[orig_patent_app_number] => 09828825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6780188 [patent_doc_number] => 20030051270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Targeted chromosomal genomic alterations with modified single stranded oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/818875 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47926 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20030051270.pdf [firstpage_image] =>[orig_patent_app_number] => 09818875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145448 [patent_doc_number] => 06773881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'Methods of modulating hair growth' [patent_app_type] => B2 [patent_app_number] => 09/813640 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20329 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773881.pdf [firstpage_image] =>[orig_patent_app_number] => 09813640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276239 [patent_doc_number] => 20020106723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Receptor for latrotoxin from insects' [patent_app_type] => new [patent_app_number] => 09/808571 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5254 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106723.pdf [firstpage_image] =>[orig_patent_app_number] => 09808571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843448 [patent_doc_number] => 20020131959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Means and methods for the modulation of arteriogenesis' [patent_app_type] => new [patent_app_number] => 09/805432 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7229 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20020131959.pdf [firstpage_image] =>[orig_patent_app_number] => 09805432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985117 [patent_doc_number] => 20020098199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences' [patent_app_type] => new [patent_app_number] => 09/802370 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098199.pdf [firstpage_image] =>[orig_patent_app_number] => 09802370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000598 [patent_doc_number] => 20020028783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Method of stimulating prosaposin receptor activity' [patent_app_type] => new [patent_app_number] => 09/802617 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3487 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028783.pdf [firstpage_image] =>[orig_patent_app_number] => 09802617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177792 [patent_doc_number] => 20020156033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 09/800266 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25844 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156033.pdf [firstpage_image] =>[orig_patent_app_number] => 09800266 [rel_patent_id] =>[rel_patent_doc_number] =>)